HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marie-Luise Arnold Selected Research

Nitracrine (C 283)

1/2009Pharmacogenetic testing for guiding de novo phenprocoumon therapy in stroke patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marie-Luise Arnold Research Topics

Disease

2Stroke (Strokes)
01/2009 - 10/2008
1Inflammation (Inflammations)
01/2021
1Venous Thrombosis (Deep-Vein Thrombosis)
02/2009
1Transient Ischemic Attack
01/2009
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2009
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
05/2002

Drug/Important Bio-Agent (IBA)

1AntibodiesIBA
01/2021
1IgG Receptors (Fc gamma RI)IBA
01/2021
1Glutathione PeroxidaseIBA
02/2009
1Nitracrine (C 283)IBA
01/2009
1Phenprocoumon (Liquamar)FDA Link
01/2009
1Vitamin K Epoxide ReductasesIBA
10/2008
1AutoantibodiesIBA
05/2002

Therapy/Procedure

1Therapeutics
01/2009
1Secondary Prevention
01/2009